Legend Biotech LEGN
NASDAQ LEGN
$19.89 +1.07 (+5.69%)
At close: Sep 30, 2026 · 4:00 PM EDT

Legend Biotech (LEGN) Total Non-Current Liabilities (2019 - 2026)

Updated

Legend Biotech's Total Non-Current Liabilities was $117.7 million in Q2 2026, down 69.7% from $388.89 million a year earlier and down 1.8% from the prior quarter.

Analysis

Legend Biotech (LEGN) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Legend Biotech came in at $95.2 million, down 72.9% from FY2024.

  • Total Non-Current Liabilities shows a five-year compound annual growth rate of 61.2% (FY2020 to FY2025).
  • In earlier years, Total Non-Current Liabilities was $351.9 million in FY2024 (-7.6%), $380.82 million in FY2023 (+31.8%), $288.86 million in FY2022 (+132.4%) and $124.32 million in FY2021.
  • Quarterly Total Non-Current Liabilities has moved between $95.2 million (Q4 2025) and $388.89 million (Q2 2025) over five years.
  • Compared with a year earlier, Total Non-Current Liabilities has declined for four straight quarters, with an average decline of 27.4% over the last eight quarters.
  • The best year-over-year quarter for Total Non-Current Liabilities over five years was Q4 2022 (growth of 132.4%); the worst was Q4 2025 (a decline of 72.9%).
  • Per Business Quant data, LEGN's Total Non-Current Liabilities in the three quarters before Q2 2026 was $119.9 million (Q1 2026), $95.2 million (Q4 2025) and $268.12 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Legend Biotech 3.67 Bn -74.25 Mn 251.50 Mn 117.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 117.70 Mn
Mar 31, 2026 119.90 Mn
Dec 31, 2025 95.20 Mn
Sep 30, 2025 268.12 Mn
Jun 30, 2025 388.89 Mn
Mar 31, 2025 363.53 Mn
Dec 31, 2024 351.90 Mn
Sep 30, 2024 348.82 Mn
Jun 30, 2024 344.88 Mn
Mar 31, 2024 361.37 Mn
Dec 31, 2023 380.82 Mn
Sep 30, 2023 324.48 Mn
Jun 30, 2023 322.25 Mn
Mar 31, 2023 318.02 Mn
Dec 31, 2022 288.86 Mn
Mar 31, 2022 376.42 Mn
Dec 31, 2021 124.32 Mn
Sep 30, 2021 312.53 Mn
Jun 30, 2021 274.11 Mn
Mar 31, 2021 262.86 Mn
API Access

Legend Biotech Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=LEGN&period=max&api_key=YOUR_API_KEY